跳至主要内容
临床试验/NCT07421180
NCT07421180已完成不适用

Maternal Serum Adropin as a Potential Biomarker for Placenta Accreta Spectrum

Adana City Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2024年5月15日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
1
主要终点
Blood serum Adropin levels

研究概览

简要总结

Aim: To compare maternal serum adropin levels in pregnancies complicated by placenta previa and/or placenta accreta spectrum (PAS) with those of healthy pregnant women and to evaluate the diagnostic value of adropin for predicting placental invasion.

Methods:

This cross-sectional study included 84 singleton pregnancies at ≥34 weeks of gestation: 42 women diagnosed with placenta previa and/or PAS and 42 healthy pregnant women who underwent cesarean delivery. Maternal serum adropin levels are measured preoperatively using enzyme-linked immunosorbent assay. Demographic, obstetric, ultrasonographic, and intraoperative findings were recorded. Receiver operating characteristic (ROC) curve analysis is performed to assess the predictive performance of adropin for PAS.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women aged 18-45 years in the reproductive period
  • Singleton, viable third-trimester pregnancies diagnosed with placenta previa and/or PAS

排除标准

  • Uterine anomalies,
  • Chronic systemic diseases,
  • Multiple pregnancies,
  • Obstetric complications such as preterm premature rupture of membranes, threatened preterm labor, fetuses followed for intrauterine growth restriction, and placental abruption.

研究组 & 干预措施

control group

healthy pregnant women in the third trimester with similar demographic characteristics

Study group (Diagnosed with Plasenta Previa and/or Placenta accreta spectrum)

Pregnant women aged 18-45 years viable third-trimester pregnancies diagnosed with placenta previa and/or PAS (Placenta accreta spectrum)

结局指标

主要结局

Blood serum Adropin levels

时间窗: From 15.04.2024 to 01.04.2025

The aim of the present study was to evaluate maternal serum adropin levels in pregnancies complicated by placenta previa and placenta accreta spectrum and compare to healthy controls.

次要结局

未报告次要终点

研究者

发起方
Adana City Training and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gulsum Uysal

Professor Gulsum Uysal

Adana City Training and Research Hospital

研究点 (1)

Loading locations...

相似试验